FDA Inspection 1244070 — Miami Cancer Institute IRB At Baptist Health Inc.
The FDA completed an inspection of Miami Cancer Institute IRB At Baptist Health Inc. on Jul 11, 2024 in Miami, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 11, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Miami, FL (United States)
Additional Details
IRB